Spencer Pharmaceutical Mandates Independent Laboratory to Validate Met4 Findings

BOSTON, MA--(Marketwire - October 28, 2010) -

(PINKSHEETS: SPPH) Spencer Pharmaceutical Inc. announced today that an independent laboratory has been mandated to validate the met4 findings.

According to the mandate, the independent laboratory will perform the animal testing to validate the release time and efficiency of the new Spencer met4 formulation.

“Management believes that the independent laboratory will significantly increase the visibility of Spencer. These tests are straightforward and can be accomplished over the next month or so,” stated Dr. Max Arella, President of Spencer Pharmaceutical Inc. Furthermore, “Tests are not only necessary but may help us in adding value to future licensing deals and can potentially provide significant revenue stream for the company in the near and long term while creating significant share hold value.”

About Spencer Pharmaceutical Inc.

Spencer Pharmaceutical Inc. is a US based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome.

Important Information

About Forward-Looking Statements in this press release may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above. In addition, such statements could be affected by risks and uncertainties related to the exploration for and development of mineralized material, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Company’s website does not constitute a part of this release.